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Neuronal nitric oxide synthase inhibition sensitizes the
tubuloglomerular feedback mechanism after volume expansion
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Neuronal nitric oxide synthase inhibition sensitizes the tubu-
loglomerular feedback mechanism after volume expansion.
Background. In the kidney the neuronal isoform of nitric ox-
ide synthase (nNOS) is located in the macula densa cells. These
cells are known to be the sensor in the tubuloglomerular feed-
back. During volume expansion (VE), the tubuloglomerular
feedback response is attenuated, allowing increased water and
salt excretion. This study addressed the question whether in-
hibition of nNOS reestablishes the tubuloglomerular feedback
response caused by acute extracellular VE.
Methods. In rats, VE was achieved by infusion of isotonic
saline solution at 50 mL/hour ∗ kg body weight. When urine flow
was stabilized, the tubuloglomerular feedback response was
evaluated by measuring changes in proximal tubular stop-flow
pressure (PSF) in response to various loop of Henle perfusion
rates. The loop of Henle was perfused with artificial ultrafiltrate
and with addition of 1 mol/L non-specific NOS inhibitor, Nx-
nitro-L-arginine methyl ester (L-NAME). In additional rats the
nNOS inhibitor, 7-nitro indazole (7-NI), was given intraperi-
toneally. Single nephron glomerular filtration rate (SNGFR)
was also measured. GFR was determined after VE and nNOS
inhibition.
Results. Acute VE decreased PSF and SNGFR while in-
creasing the turning point, indicating decreased sensitivity of
tubuloglomerular feedback response. After administration of
L-NAME or 7-NI, PSF was maximally sensitized and the turn-
ing point and SNGFR were restored. GFR decreased after
VE and nNOS inhibition compared to that after VE alone.
Conclusion. These results suggest that a functioning nitric
oxide system, especially through the nNOS, is important in
mediating normal renal responses and that increased produc-
tion of and/or sensitivity to nitric oxide during sustained VE
plays an important role in the adaptive mechanism of the tubu-
loglomerular feedback.
Salt and water overload is a condition that can occur in
human beings and animals. The body therefore has pow-
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erful mechanisms to excrete excess fluid volumes and salt
that would otherwise endanger the life of the organism.
In the mammalian kidney there is accurate control of
tubular reabsorption, with appropriate adjustment of the
glomerular filtration rate (GFR). One of the most impor-
tant factors in this control process is the tubuloglomerular
feedback mechanism located in the juxtaglomerular ap-
paratus. This mechanism operates by sensing the tubular
load to the distal tubule via the Na+/K+/2 Cl− cotransport
at the macula densa site, sending signals to the rest of the
apparatus to adjust the tonus of the glomerular arterioles,
which regulates GFR [1, 2]. The sensing step in this con-
trol mechanism, the macula densa cells, is located in the
distal tubule at the point of contact with the glomerulus
and the glomerular arterioles.
From earlier studies it is known that the sensitivity of
the tubuloglomerular feedback mechanism can be reset
by several different factors. Many hormones and local
factors such as prostaglandins, angiotensin II, thrombox-
ane, and others can reset the tubuloglomerular feedback
sensitivity by altering its response curve [3, 4]. Soon af-
ter the tubuloglomerular feedback operation had been
characterized in detail, it became clear that changes in
the body fluid volume were associated with changes in
the sensitivity of the tubuloglomerular feedback mech-
anism. Under conditions of volume expansion a reset-
ting of tubuloglomerular feedback to a low sensitivity
was found [5]. This indicated that a high tubular flow was
needed to activate the tubuloglomerular feedback. This
allows a greater fluid flow to pass the macula densa cells
without contraction of the glomerular arterioles, leading
to reduced glomerular filtration.
Nitric oxide is involved in many functions and con-
ditions throughout the body, including vasodilatation,
cell growth, inflammation, neurotransmission, hormone
release, and renal sodium handling etc. Nitric oxide is
formed together with L-citrulline from L-arginine and
oxygen by the enzyme nitric oxide synthase (NOS). There
are three known isoforms of NOS, the neuronal isoform
(nNOS), the inducible isoform (iNOS), and the endothe-
lial isoform (eNOS). The nNOS and the eNOS iso-
forms are constitutively expressed and Ca2+-dependent,
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while iNOS is considered to be inducible and Ca2+-
independent. However, it has been reported that iNOS
is also constitutively expressed in the kidney [6, 7]. In the
kidney the macula densa cells have been found to contain
a high density of nNOS [8–10]. It has also been found
that the nitric oxide system has an important function
in the tubuloglomerular feedback mechanism [11, 12]. It
has been reported that nitric oxide produced in the juxta-
glomerular apparatus can influence glomerular capillary
pressure and the tubuloglomerular feedback mechanism
[11, 12]. Acute blockade of nitric oxide with Nx-Nitro-l-
arginine (L-NNA) resets tubuloglomerular feedback sen-
sitivity to a high level, implying that nitric oxide is pro-
duced continuously in the juxtaglomerular apparatus to
reduce the tubuloglomerular feedback sensitivity. Most
of this effect of nitric oxide seems to be attributed to ni-
tric oxide produced by nNOS located in the macula densa
cells, since 7-nitro indazole (7-NI), a relatively selective
nNOS inhibitor, reduces tubuloglomerular feedback sen-
sitivity to the same extent as L-NNA when administered
into the tubular lumen [13].
Since volume expansion (VE) and increased nitric ox-
ide production result in a decrease in tubuloglomerular
feedback sensitivity, the present investigation was under-
taken to determine to what extent nitric oxide is involved
in the effect of tubuloglomerular feedback sensitivity re-
setting that occurs upon extracellular VE. To study this
question, we measured the tubuloglomerular feedback
response in rats with acute saline VE after general NOS
inhibition and specific inhibition of nNOS. This response
was elucidated both with a stop-flow technique and by
measurement of the single nephron glomerular filtration
rate (SNGFR). We also measured GFR after VE and
inhibition of nNOS. We found that the tubuloglomeru-
lar feedback sensitivity, which was reset to a low level
after VE, could be restored to a normal or even supra-
normal level, as observed both from the stop-flow pres-
sure and by SNGFR measurements by blockade of the
NOS system. These results indicate that the resetting of
the tubuloglomerular feedback mechanism to a low sen-
sitivity that occurs during VE takes place by increased
production of nitric oxide through activation of the NOS
system.
METHODS
The experiments were performed on male Sprague-
Dawley rats (Møllegaard, Copenhagen, Denmark)
weighing 220 to 340 g. The rats were anesthetized with
an intraperitoneal injection of Inactin (thiobutabarbi-
tal sodium, 120 mg/kg) Sigma Chemical Co., St. Louis,
MO, USA).
Surgery
The animals were placed on a servo-controlled heating
pad to maintain the body temperature at 37.5◦C. A tra-
cheostomy was performed to allow spontaneous breath-
ing. The carotid artery and jugular vein were cannulated
for blood pressure measurements and infusion of main-
tenance fluid (0.9% NaCl, 5 mL/hour ∗ kg), respectively.
The bladder was catheterized for urine collection. For ex-
periments involving micropuncture, the left kidney was
exposed through a subcostal flank incision. The kidney
was dissected free from surrounding tissue, placed in a
plastic cup, and fixed with a 3% agar solution. The ureter
of the left kidney was cannulated to allow free urine flow.
The kidney was covered with oil to prevent drying. A 5%
VE was achieved after surgery by increasing the infusion
rate to 50 mL/hour ∗ kg saline for 60 to 90 minutes and
then adjusting it to match the urine flow. When the urine
flow was stabilized, the tubuloglomerular feedback char-
acteristics were evaluated.
Experimental protocols
The rats were divided into four groups, treated in dif-
ferent ways as described and submitted to stop-flow and
single nephron GFR (SNGFR) measurements.
Normovolemic controls (NC). After the surgical
preparations, saline was infused continuously at 5 mL/
hour ∗ kg and after 90 minutes of equilibration stop-flow
measurements were made or SNGFR was determined
(N = 5 nephrons/3 rats).
Volume expansion controls (VEC). After surgery,
saline was infused continuously at 50 mL/hour ∗ kg and
after 90 minutes of equilibration stop-flow measurements
were made or SNGFR was determined (N = 9 nephrons
studied/5 rats studied).
Volume expansion, intratubular NOS inhibition
(VEL-NAME). After surgery, saline was infused con-
tinuously at 50 mL/hour ∗ kg and after 90 minutes of
equilibration stop-flow measurements were made or
SNGFR was made (N = 8 nephrons/5 rats) with addition
of the nonspecific NOS inhibitor Nx-nitro-L-arginine
methyl ester (L-NAME) (10−3 mol/L) to the artificial
ultrafiltrate.
Volume expansion, nNOS inhibition (VE7-NI). After
surgery, saline was infused continuously at 50 mL/hour ∗
kg. After 90 minutes of equilibration, a single intraperi-
toneal dose of 25 mg/kg of the specific nNOS inhibitor
7-NI (Sigma Chemical Co.), dissolved in heated (80◦C)
peanut oil (Sigma Chemical Co.), was administered, and
a minimum of 15 minutes was allowed before either stop-
flow measurements were performed or SNGFR was de-
termined (N = 7 nephrons/4 rats).
Stop-flow pressure measurements
Tubuloglomerular feedback characteristics were de-
termined by the stop-flow technique. Randomly chosen
proximal tubular segments on the kidney surface were
punctured with a sharpened glass pipette [outer diameter
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(OD) 3 to 5 lm] filled with a 1 mol/L NaCl solution stained
with Lissamine green. The pipette was connected to a
servo-nulling pressure system (World Precision Instru-
ments, New Haven, CT, USA) to determine the proximal
tubular free-flow pressure (PT). By injections of stained
fluid, the tubular distribution on the kidney surface was
defined. In nephrons in which more than three proxi-
mal tubule segments were identified, a second pipette
(OD 7 to 9 lm) was inserted in the last accessible seg-
ment. This pipette was filled with an artificial ultrafiltrate
(140 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L CaCl2, 1
mmol/L MgCl2, 4 mmol/L NaHCO3, 7 mmol/L urea, and
2 g/L Lissamine green, pH 7.4) and connected to a microp-
erfusion pump (Hampel, Frankfurt, Germany). Between
these two pipettes a solid wax block was placed with a
third pipette (OD 7 to 9 lm). The pressure upstream to
the block, the proximal tubular stop-flow pressure (PSF),
was determined at different perfusion rates in the loop
of Henle with artificial ultrafiltrate. The maximal change
in stop flow pressure (PSF) was used to indicate tubu-
loglomerular feedback reactivity and the tubular flow
rate eliciting half-maximal PSF, the turning point (TP),
served to indicate tubuloglomerular feedback sensitivity.
For plotting the response curve in Figure 1, normalized
data were fitted to the following equation by means of a
nonlinear least-squares curve-fitting program:
PSF = PSF,min + PSF/1 + ew(PR−TP)
where PSF is the stop-flow pressure, PSF is the average
maximal stop-flow response, and PSF,min is the average
minimum stop-flow pressure when the distal delivery of
fluid is increased. TP is the turning point, PR is the end-
proximal perfusion rate and w is the factor determining
the width of the perfusion interval during which the PSF
responded. It should be mentioned that PSF is not always a
perfect measure of tubuloglomerular feedback sensitivity
or activity [14].
SNGFR measurements
For measuring SNGFR, [3H] methoxy-inulin (NEN,
Boston, MA, USA) was given intravenously as a bolus
dose of 25 lCi, followed by a continuous intravenous in-
fusion of 50 lCi/hr. SNGFR characteristics were deter-
mined by micropuncture techniques. Randomly chosen
tubular segments on the kidney surface were punctured
with a sharpened glass pipette, filled with artificial ul-
trafiltrate (140 mmol/L NaCl, 5 mmol/L KCl, 2 mmol/L
CaCl2, 1 mmol/L MgCl2, 4 mmol/L NaHCO3, 7 mmol/L
urea, and 2 g/L Lissamine green, pH 7.4), connected to a
microperfusion pump (Hampel). By injecting the stained
fluid, the tubular distribution on the kidney surface was
defined. A pipette filled with castor oil was injected into
a tubular segment. Proximal to the oil block, tubular fluid
was collected for 3 minutes while the nephron distal to
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Fig. 1. Proximal tubular stop-flow pressure at different rates of tubular
perfusion. Curves are results of fitting of normalized data from rats in a
normovolemic control situation (NC) and after 5% extracellular volume
expansion (VEC) (A), and from rats treated with combinations of 5%
VE and intratubular infusion of Nx-nitro-L-arginine methyl ester (L-
NAME) (VEL-NAME) (B), or intraperitoneal administration of 7-nitro
indazole (7-NI) (VE7-NI) (C).
the oil block was perfused. In some experiments either L-
NAME was added to the perfusion fluid or 7-NI was given
intraperitoneally. In the experiments where L-NAME
was used, the inhibitor was used to perfuse the nephron at
a rate of 10 nL/min between SNGFR investigations and
also in the periods between tubuloglomerular feedback
determinations. A change in perfusion rate from 10 to
40 nL/min always gave the same result as an increase from
0 to 40 nL/min. The volumes of the collected samples were
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measured in constant-bore capillaries. Clearance calcula-
tions were made from standard formulas.
GFR measurements
Measurements of the urine flow rate, Na+ and K+ ex-
cretion, and GFR were commenced after 1 hour of con-
tinuous saline infusion at 5 mL/hour ∗ kg. Urine from
both kidneys was sampled through a catheter placed in
the bladder. After completion of surgery, infusion of [3H]
methoxy-inulin in normal saline into the jugular vein was
commenced. In whole kidney clearance measurements
a continuous dosage of 5 lCi/hour was given. After an
equilibration period of 60 minutes, a 20-minute urine
collection period was begun, and this was followed by
a bolus intraperitoneal dose of 7-NI (25 mg/kg). Fifteen
minutes after the 7-NI administration a second 20-minute
urine collection period was begun. The urine volume was
determined by weight. At the midpoint of the collec-
tion periods, blood samples were taken. These samples
were centrifuged and aliquots of plasma were analyzed
in a multipurpose scintillation counter (Beckman LS
6500) (Beckman Industries, Inc., Fullerton, CA, USA),
together with aliquots of urine. Inulin clearance was then
calculated as a measure of GFR. The concentrations of
sodium and potassium were assayed with a flame pho-
tometer (FLM 3) (Radiometer, Copenhagen, Denmark).
Statistics
The results are presented as mean ± SEM. Differences
between the groups were tested for significance with Stu-
dent t test for paired or unpaired observations. When mul-
tiple groups were compared, one-way analysis of variance
(ANOVA) was employed. The Bonferroni test for pair-
wise multiple comparisons was used to allow for more
than one comparison with the same variable. This states
a significance level of P/M, where M is the number of com-
parisons to be made. Statistical significance was defined
as P < 0.05.
RESULTS
The mean arterial pressures in the animals used in the
different groups were constant throughout the experi-
ments (NC, 118 ± 2.6 mm Hg; VEC, 123 ± 2.9 mm Hg;
VEL-NAME, 124 ± 3.7 mm Hg; and VE7-NI, 129 ± 6.1 mm
Hg) and did not differ after induction of 5% extracellular
VE or addition of L-NAME or 7-NI. The hematocrit was
47.4% ± 0.3% during normovolemia and fell to 44.2%
± 0.4% after initiation of VE; thereafter it remained
constant.
Stop-flow pressure measurements
The influence of intratubular infusion of L-NAME or
intraperitoneal administration of 7-NI on the characteris-
tics of the tubuloglomerular feedback is shown in Table 1
and in Figures 1 and 2. Throughout the stop-flow pressure
Table 1. Tubuloglomerular feedback characteristics in normovolemic
control rats (NC) and in rats submitted to volume expansion (VE) and
Nx-nitro-L-arginine methyl ester (L-NAME) or 7-nitro indazole
(7-NI)
NC VEC VEL-NAME VE7-NI
Pa mm Hg 118 ± 2.6 119 ± 2.9 121 ± 3.3 127 ± 3.7
PT mm Hg 13.2 ± 0.3a 21.0 ± 0.9b 21.0 ± 0.9b 18.7 ± 1.2b
PSF mm Hg 42.2 ± 0.8 45.2 ± 0.8 42.5 ± 0.6 45.6 ± 1.8
TP nL/min 20.3 ± 0.8a 32.9 ± 2.6 20.5 ± 1.2a 22.1 ± 1.7a
PSF mm Hg 9.9 ± 0.3a 2.7 ± 0.6 14.7 ± 1.3a 17.7 ± 2.3a,b
%PSF 23.5 ± 0.7a 6.0 ± 1.3 34.5 ± 3.0a 38.8 ± 5.1a.b
N/M 7/5 7/5 7/5 6/5
Abbreviations are: Pa, blood pressure; PT, proximal tubular pressure; PSF, prox-
imal tubular stop-flow pressure; TP, turning point; M, rats; N, nephrons. Values
are given as mean ± SE.
aP < 0.05 vs. VEC; bP < 0.05 vs. NC.
measurements, blood pressure (Pa) remained stable. Al-
though Pa had a tendency to be higher in the VE group
treated with 7-NI (VE7-NI), this was not statistically sig-
nificant. In the NC group, proximal tubular pressure (PT)
was 13.2 mmHg. Acute VE caused an elevation of PT to
18 to 21 mm Hg in all of the three VE groups. Despite this
increase in PT, acute VE did not seem to affect PSF. In all
of the four groups PSF was similar, averaging between 42
and 45 mm Hg. Measurements of PSF at different perfu-
sion rates of the loop of Henle showed that VE greatly
affected the tubuloglomerular feedback. Acute VE led to
a significant decrease in the reactivity of tubuloglomeru-
lar feedback response, as seen by the changes in maximal
stop-flow pressure response (PSF) from 9.9 mm Hg in
the NC group to 2.7 mm Hg in the VEC group (from
23.5% to 6.0%). The flow rate eliciting a half-maximal
PSF response (i.e., TP) increased significantly from 20.3
to 32.9 nL/min following VE, showing a great attenuation
in the sensitivity of the tubuloglomerular feedback. When
the loop of Henle was perfused with L-NAME, PSF in-
creased fourfold in the VE rats to 34.5%, compared to the
VEC group. At the same time TP was reset back to the
control level found in the NC group, from 32.9 to 20.5 nL/
min, which was seen as a leftward shift in the response
curve in Figure 1. When the animals were treated with 7-
NI, there was a more than fivefold increase in PSF (from
6.0% to 38.8%). The magnitude of the tubuloglomerular
feedback response was even greater than that found in
the NC group and similar to the response observed pre-
viously with 7-NI treatment of control animals [12]. As
seen with L-NAME, inhibition of nNOS with 7-NI also
restored the sensitivity of the tubuloglomerular feedback
to that noted in the NC animals (from 32.9 to 22.1 nL/min).
SNGFR measurements
The results of the SNGFR measurements are summa-
rized in Figure 2. During this series of late proximal mi-
cropuncture collections, the loop perfusion rate increased
from 0 to 40 nL/min, resulting in maximal activation
of the tubuloglomerular feedback mechanism. In the NC
animals. the maximal decrease in SNGFR that occurred
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Fig. 2. Single nephron glomerular filtration
rate (SNGFR) measured at loop perfu-
sion rates of 0 and 40 nL/min under nor-
movolemic control conditions (NC) (A),
after 5% extracellular volume expansion
(VEC) (B), and after treatment with com-
bination of 5% VE and intratubular in-
fusion of Nx-nitro-L-arginine methyl ester
(L-NAME) (VEL−NAME) (C), or of 5%
VE and intraperitoneal administration of 7-
nitro indazole (7-NI) (VE7-NI) (D). ∗P <
0.05 vs. VEC.
when the perfusion rate was increased to 40 nL/min was
7.8 ± 1.4 nL/min (38.3% ± 3.4% per 100 g body weight).
In the VEC group no such reduction was observed when
the perfusion rate was increased (0.85 ± 0.2 nL/min;
4.9% ± 0.9% per 100 g body weight), indicating dimin-
ished tubuloglomerular feedback activity. Addition of L-
NAME to the tubular perfusion fluid had a great effect
on the SNGFR and restored the response to the same
level as was observed in the NC group (7.8 ± 1.1 nL/min;
39.2% ± 3.5% per 100 g body weight). The VE7-NI group
also showed an increase in TGF activity, with a decrease
in SNGFR by 9.3 ± 2.4 nL/min (37.3% ± 7.8%), when
the loop perfusion rate was increased, and the response
was thus restored to the normovolemic level.
GFR measurements
Mean arterial pressure was not significantly altered af-
ter 7-NI administration (Table 2). Acute nNOS inhibition
with 7-NI after volume expansion decreased GFR. Salt
excretion values are also given in Table 2. The elevated
Na+ and osmolar excretions were increased after admin-
Table 2. Mean arterial pressure, whole kidney glomerular filtration
rate (GFR) and excretion rates of sodium, potassium, and osmolites
in rats after a 5% extracellular volume expansion (VEC) in the
control period and after inhibition of neuronal nitric oxide synthase
(nNOS) [volume expansion of 7-nitro indazole (VE7-NI)
VEC VE7-NI
Mean arterial pressure mm Hg 136 ± 5 140 ± 8
GFR mL/min ∗ g kidney weight 1.13 ± 0.14 0.92 ± 0.08a
[Na]excr lmol/min ∗ g kidney weight 3.35 ± 0.60 4.93 ± 0.96a
[K]excr lmol/min ∗ g kidney weight 1.08 ± 0.13 1.03 ± 0.09
[Osm]excr losmol/min ∗ g kidney weight 12.07 ± 1.04 14.58 ± 1.65a
Hematocrit % 44 ± 1 44 ± 2
Abbreviations are: [Na]excr, sodium excretion rate; [K]excr, potassium excretion
rate; [Osm]excr, osmolar excretion rate. Values are mean ± SE.
aP < 0.05.
istration of 7-NI, while the K+ excretion was unaltered
following this nNOS inhibition.
DISCUSSION
The main finding in the present study is that inhibition
of nNOS, with the specific inhibitor 7-NI, sensitizes the
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greatly attenuated tubuloglomerular feedback response
to a higher than normal reactivity and decreases the GFR
after 5% extracellular VE. Thus, our results indicate that
macula densa–derived nitric oxide is a mandatory par-
ticipant in the tubuloglomerular feedback resetting that
occurs in response to extracellular VE.
Experiments employing different techniques and
approaches have shown the existence of the basic tubu-
loglomerular feedback loop in the juxtaglomerular appa-
ratus [15]. Resetting of the tubuloglomerular feedback
to a lower level during VE, as was observed in this study,
is an important mechanism, since the attenuation of the
tubuloglomerular feedback response allows a greater dis-
tal delivery of fluid before a tubuloglomerular feedback–
induced reduction of the GFR takes place [5, 16, 17]. This
can be seen in Figure 1A as a rightward shift of the tubu-
loglomerular feedback response curve. This adaptation of
the tubuloglomerular feedback response plays a part in
facilitating the return of the extracellular fluid volume to a
normovolemic level. If no resetting of the tubuloglomeru-
lar feedback occurred, the tubuloglomerular feedback–
induced vasoconstriction of the afferent arteriole would
reduce the GFR and thereby prevent an adjustment of
the extracellular fluid volume.
The mechanisms underlying the resetting process are
complex and derive from many different sources, and
the resulting sensitivity of the tubuloglomerular feedback
will be influenced by several factors. However, it appears
as if some factors are of greater importance than others.
It seems that angiotensin II, nerve stimulation, and nitric
oxide all have powerful influence on the setting of the
sensitivity of the tubuloglomerular feedback mechanism
[9, 18, 19].
It has been reported that angiotensin II can importantly
sensitize the tubuloglomerular feedback mechanism in a
situation with volume expansion [18]. The authors of that
study demonstrated that after a large volume expansion
the tubuloglomerular feedback sensitivity was reduced,
as also was the plasma concentration of angiotensin II.
Subsequently, the tubuloglomerular feedback sensitivity
could be increased by infusion of angiotensin II. With
large doses of angiotensin II they were able to maximally
sensitize the tubuloglomerular feedback sensitivity, but
when they restored the angiotensin II concentration to
the same level as they found in euvolemia, they observed
an increase in reactivity (PSF) from 6% to 12%. Earlier
studies at our laboratory in the control state showed a
shift in turning point from 18 to 14 nL/min and an increase
in the stop-flow pressure response from 20% to 36%,
while the corresponding changes in the present study dur-
ing 7-NI administration were from 20 to 22 nL/min and
23.5% to 38.5%. The shift in turning point was less pro-
nounced in the present study, but the change in reactivity
was the same, indicating almost maximal tubuloglomeru-
lar feedback sensitivity.
In the resetting during VE one important causative
factor of a reduction of tubuloglomerular feedback
sensitivity is obviously a decrease in the angiotensin II
concentration. Furthermore, VE causes reduced sympa-
thetic activation and reduced nerve stimulation to the
renal nerves, which could also lower the tubuloglomeru-
lar feedback sensitivity [20]. In addition to these nervous
or general hormonal factors, local factors may also play
an important role. Prior studies at our laboratory have
addressed he question whether the resetting of the tubu-
loglomerular feedback response following VE depends
on extrarenal or local intrarenal factors [21]. By reduc-
ing the colloid osmotic pressure in the peritubular capil-
lary network, the tubuloglomerular feedback sensitivity
could be reset to a lower level [21], indicating that altered
activity of the tubuloglomerular feedback system during
VE might be achieved via locally derived factors. Stud-
ies by Morsing and Persson [22] indicate that bradykinin
is responsible for the resetting of the tubuloglomerular
feedback sensitivity during VE. Aprotinin, a blocker of
bradykinin formation could also inhibit the reduction
in tubuloglomerular feedback sensitivity caused by VE
[22]. The same authors also found that administration of
bradykinin to euvolemic animals could reset the tubu-
loglomerular feedback sensitivity to a low level. Thus,
one possible explanation for the tubuloglomerular feed-
back resetting during VE could be that VE leads to a lo-
cal release of bradykinin within the kidney, which in turn
could increase prostaglandin (prostacyclin) release in the
renal interstitium [23]. Concerning the mechanism of the
resetting, it may be speculated that bradykinin could re-
lease intracellular calcium in the macula densa cells as in
other renal epithelial cells [24, 25], and that this increase
in calcium in the macula densa cells could then stimulate
the formation of nitric oxide from calcium-calmodulin–
dependent nNOS and in this way counteract the affer-
ent arteriolar constriction. Nitric oxide could vasodilate
the renal vasculature and thereby increase the intersti-
tial hydrostatic pressure and reduce interstitial oncotic
pressure. Such interstitial pressure changes are known to
be associated with a reduced tubuloglomerular feedback
sensitivity [26].
Earlier studies have indicated that nNOS is greatly ex-
pressed in the macula densa cells [8–10]. It seems that
this NOS has an important function in tonically influenc-
ing the tubuloglomerular feedback mechanism to reduce
its sensitivity and reactivity [27]. Studies of the tubu-
loglomerular feedback mechanism through PSF measure-
ments indicated that tubular inhibition of NOS with a
general NOS inhibitor shifts the tubuloglomerular feed-
back response to a low TP, indicating a high sensitivity
and a large reactivity [27]. Hence, nitric oxide production
continuously desensitizes the tubuloglomerular feedback
mechanism. Furthermore, it has been shown that this ef-
fect is mediated mainly by the action of nNOS and not by
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other NOS isoforms [12, 13]. Thus, an increased produc-
tion of nitric oxide from nNOS would lead to a shift of the
tubuloglomerular feedback sensitivity to a higher TP and
reduced reactivity. It has recently been demonstrated that
an increased sodium chloride concentration at the macula
densa site in isolated perfused thick ascending limbs with
attached glomeruli increases nitric oxide release [28]. It
would therefore be expected that during VE, when the
distal delivery of fluid is increased, the sodium chloride
concentration at the macula densa would be raised. This
would then lead to an increased rate of production of
nitric oxide by the macula densa cell.
In the present study we found that extracellular
VE reduced the reactivity and sensitivity of the tubu-
loglomerular feedback response, as seen both in the
PSF and SNGFR measurements. General NOS inhibition
achieved through L-NAME or nNOS inhibition with 7-NI
restored the tubuloglomerular feedback sensitivity to the
control level, while the tubuloglomerular feedback reac-
tivity was maximal. Thus, these findings indicate that in a
situation with a low angiotensin II concentration and low
sympathetic tone, as in volume expansion, nitric oxide
essentially controls the full range of tubuloglomerular
feedback sensitivity. Nitric oxide blockade by tubular ad-
ministration of L-NAME returns the reactivity in a mat-
ter of seconds to the maximal achievable, and the turning
point to the control level. It is also interesting to note that
7-NI gives rise to a significant decrease in total kidney
GFR that can be explained on the basis of the increased
tubuloglomerular feedback sensitivity during VE on ad-
ministration of the drug.
Many investigators have studied the effect of different
salt diets on the nNOS expression in the macula densa
cells. In these cells there seems to be an inverse relation-
ship between a salt diet and long-term nNOS expression
[29–31]. Even though nNOS expression is increased after
low salt treatment, the nitric oxide produced by macula
densa nNOS is not elevated [32, 33]. This is probably
due to limited delivery and/or uptake of L-arginine in
this situation [32, 34]. It has been shown that both short-
term saline infusion and chronic dietary NaCl loading
increases the nitric oxide production in the kidney [35,
36]. Wilcox, Deng, and Welch [33] found that after 8 to
10 days of a high salt diet the excretion of NO2 and
NO3 was increased. This increase seemed to be medi-
ated through the nNOS derived nitric oxide [33]. This
is in line with our finding that the resetting of the tubu-
loglomerular feedback response after VE was restored in
the nNOS-inhibited rats, as seen both in the PSF and the
SNGFR measurements.
In the experiments in which whole kidney GFR was
measured after extracellular VE, we noted that GFR was
attenuated by nNOS inhibition. In an earlier study [13],
we found a decrease in GFR after acute nNOS inhibition.
It is very likely that tubuloglomerular feedback activation
is one important factor underlying the reduction in total
kidney GFR seen after administration of 7-NI. By con-
trast, we also found increases in sodium and osmolar ex-
cretion after systemic nNOS inhibition during VE, while
the potassium excretion was unaffected. The effect of ni-
tric oxide on sodium excretion has been greatly studied,
but the results are conflicting. In vitro there is evidence
that nitric oxide has direct tubular actions leading to in-
hibition of sodium reabsorption in the proximal tubules
and collecting duct [7, 37–39]. However, in vivo the re-
sults are more variable. It has been found that nitric is
important in mediating pressure natriuresis [40, 41], but
it has also been reported that NOS inhibition gives rise
to a natriuretic response [41, 42]. It has been suggested
that this natriuretic response following NOS inhibition
and VE may be related to the renal nerves [43].
CONCLUSION
During VE the tubuloglomerular feedback response
is greatly attenuated. This resetting allows for increased
water and solute excretion, so that the extracellular fluid
volume can be normalized. Part of this resetting depends
on a reduced sympathetic tone and a reduced production
rate of angiotensin II. During VE the sensitivity of the
tubuloglomerular feedback is under the control of the
nitric oxide production rate. An inhibition of the nitric
oxide production by the macula densa cell nNOS leads
to maximal sensitization the tubuloglomerular feedback
reactivity and normalization of the turning point. Thus,
the present study also suggests that a functional nitric
oxide system is important in mediating normal renal re-
sponses and that an increased production of or increased
sensitivity to nitric oxide during volume expansion plays
an important role in the adaptive mechanisms.
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